| Product Name | NebuSelect™ Recombinant Biotinylated Cynomolgus Siglec-15/CD33L3, Avi-His-tag |
|---|---|
| Catalog Number | NBL-241923 |
| Alias/Synonyms | Siglec-15/CD33L3 |
| Appearance | see COA |
| Molecule Weight | Met60-Thr322 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | XP_005586866.2 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241923-100ug | 100ug | Inquire | Inquire | |
| NBL-241923-1mg | 1mg | Inquire | Inquire | |
| NBL-241923-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Cynomolgus Siglec-15/CD33L3, Avi-His-tag
Catalog#:
NBL-241923
Description:
NebuSelect™ Recombinant Biotinylated Cynomolgus Siglec-15/CD33L3, Avi-His-tag(Cat#NBL-241923) is expressed in HEK293 with His and Avi tag at the C-Terminus.It contains Met60-Thr322.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 29.2 kDa. Due to glycosylation, the protein migratesto 33-43 kDa based on Bis-Tris PAGE result.
Target Name:
Siglec-15/CD33L3
Target Information:
Siglec-15 is a transmembrane glycoprotein in the Siglec family of sialic acid-binding immune regulatory molecules. Mature human Siglec-15 consists of a 244 amino acid extracellular domain (ECD) with two Ig-like domains, a 21 aa transmembrane segment, and a 44 aa cytoplasmic domain. Siglec-15 is a potential therapeutic target for osteoporosis and plays a conserved regulatory role in the immune system of vertebrates.
Amino Acid Sequence:
Met60-Thr322
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.